Document is current

Article History

Received: 20 February 2025

Accepted: 14 May 2025

First Online: 4 June 2025

Declarations

:

: Evanthia Gouveri has attended conferences sponsored by Berlin-Chemie, Sanofi, AstraZeneca, Novo Nordisk, Lilly, Boehringer Ingelheim; received speaker honoraria by Boehringer-Ingelheim, Sanofi-Aventis and Menarini. Drakopanagiotakis Fotios has attended conferences sponsored by Boehringer Ingelheim. Theodoros Panou has nothing to disclose. Paschalis Steiropoulos has been an advisory board member, has received honoraria as a speaker and has attended conferences sponsored by Astra-Zeneca, Boehringer Ingelheim, Chiesi, GSK, Elpen, Guidotti, Menarini, ResMed Specialty Therapeutics and Vivisol. Dimitrios Papazoglou declares associations: with Menarini, Novo Nordisk, Astra-Zeneca, Boehringer Ingelheim and Sanofi-Aventis. Nikolaos Papanas has been an advisory board member of Astra-Zeneca, Bayer, Boehringer Ingelheim, Menarini, MSD, Novo Nordisk, Pfizer, Takeda and TrigoCare International; has participated in sponsored studies by Astra-Zeneca, Eli-Lilly, GSK, MSD, Novo Nordisk, Novartis and Sanofi-Aventis; has received honoraria as a speaker for Astra-Zeneca, Bayer, Boehringer Ingelheim, Eli-Lilly, Elpen, Menarini, MSD, Mylan, Novo Nordisk, Pfizer, Sanofi-Aventis and Vianex; and has attended conferences sponsored by TrigoCare International, Eli-Lilly, Bayer, Galenica, Novo Nordisk, Pfizer and Sanofi-Aventis. Nikolaos Papanas is an Editorial Board member of Diabetes Therapy. Nikolaos Papanas was not involved in the selection of peer reviewers for the manuscript or any of the subsequent editorial decisions.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.